Are antibiotics effective in treating human diseases?

V_TECH LOGO_squareThe World Health Organisation has indicated that there are an increasingly limited number of antibiotics available to treat human diseases effectively, and have previously issued a list of critically-important medicines that need to be protected.

Click on the link below to watch an interview with V-Tech’s CEO, Johan Oosthyuse, discussing this subject on CNBC Africa.

Posted in Uncategorized | Leave a comment

Resistance to Colistin discovered in SA poultry

ghnw20160114-084234-913NATIONAL NEWS – A national antimicrobial resistance (AMR) surveillance programme has reportedly identified and confirmed the first ever known case in South Africa of resistance to Colistin.

The antimicrobial, Colistin, while not registered locally for human use, is said to be considered an important product in animal health and welfare when used prudently.

Animal pharmaceutical company, V-Tech, that developed and runs the AMR surveillance programme reportedly used by many poultry, feedlots and piggeries in SA, said that disease-causing bacteria’s resistance to Colistin was caused by the MCR-1 gene.

“What is worrying is that this gene is already being transmitted between bacteria, such as E. coli, which can cause urinary tract and many other types of infection, and Klebsiella pneumoniae, which causes pneumonia and other infections. This suggests the potential for it to spread between other bacterial populations, increasing the resistance to microbials, or antibiotics,” said V-Tech’s CEO, Johan Oosthuyse, in a statement.

V-Tech said that it had now amended its AMR surveillance programme to include routine scanning for the MCR-1 gene. This would enable the company to advise livestock operations where the gene was identified not to use Colistin, but instead to use alternative antimicrobials.

“A strict protocol for veterinarians to prescribe Colistin for use in animals in future will be presented by V-Tech to the Department of Health by the end of January 2016. This will limit the risk of further spread of the MCR-1 gene and the resultant risk to humans, which is of concern given the increasing threat of AMR,” Oosthuyse said.

http://www.georgeherald.com/news/News/Agri-Focus/155444/Resistance-to-Colistin-discovered-in-SA-poultry#!prettyPhoto

Posted in Uncategorized | Leave a comment

Mutant superbug threat to SA poultry

image

image

Superbugs with an alarming gene have been found in South Africa in sick and dead poultry.

The bacteria are resistant to colistin, a last-resort antibiotic for humans, and have been multiplying rapidly in South Africa since 2014. The discovery of the MCR-1 gene, which makes common bacteria resistant to colistin, has raised global concerns for human health.

The MCR-1 gene in the superbugs in South Africa – identified for the first time in November in poultry and pigs in China – poses no immediate threat to consumers, since diseased birds do not go onto the shelves.

South African Poultry Association senior executive Dr Charlotte Nkuna said companies tested their birds at slaughter and retailers did regular audits on their products.

“People are unlikely to pick up anything and poultry has a mandatory withdrawal period from antibiotics before they are sold,” she said.

Resistant bacteria can spread to people through food and environmental contamination and humans can transmit them to animals.

In South Africa, the animal health company V-Tech – which has an antimicrobial resistance surveillance programme used by poultry producers, piggeries and feedlots – noted increasing colistin resistance but did not know the reason for this.

V-Tech CEO Johan Oosthuyse said: “There was a pattern of very low resistance to colistin, at about 2% to 4%, until about two years ago, when we started seeing resistance creeping up to just above 13%.

“As soon as The Lancet journal published the information about the gene, we took the resistant bacteria we had kept frozen and sent samples to the University of Bern in Switzerland.” The first results came back in January: 19 out of 25 samples with colistin resistance had the MCR-1 gene. The second batch of results came back this week: eight out of 15 samples had the gene.

“That would mean that around 6% of the sick or dead birds tested had E coli bacteria with the MCR-1 gene,” said Oosthuyse.

Professor Vincent Perreten at the Institute of Veterinary Bacteriology at the University of Bern who confirmed the MCR-1 gene in the samples, said the South African poultry industry was being proactive and courageous by sharing the results.

Theo Delport, MD of the poultry division for Astral, said: “For the past five to six years, sensitivity tests done on E colibacteria isolated from Astral’s operation have shown that colistin was a drug of choice.”

Veterinary microbiologist Moritz van Vuuren, professor emeritus at the University of Pretoria, said: “Bacteria resistant to colistin have always been present but the rate of resistance has increased, and, unfortunately, bacteria that carry mobile resistance genes against colistin.”

The scientists who picked up the gene in China reported that it can spread easily from one strain of bacteria to another.

“The MCR-1 gene is already being transmitted between common bacteria such as E coli, which can cause urinary tract and many other types of infection, and Klebsiella pneumoniae, which causes pneumonia and other infections,” Oosthuyse warned.

V-Tech has found lots of resistant bacteria among 4000 bacteria tested over the past five years but the colistin-resistant bacteria raised a red flag because colistin is critical in human medicine. In response to this threat, V-Tech stopped supplying colistin to farms where resistance to the antibiotic had been confirmed and it added routine scanning for the MCR-1 gene.

More than 60% of poultry producers in South Africa, including major producers such as Astral Foods, RLC Foods and Country Bird, use its surveillance programme.

Oosthuyse said: “A total ban on colistin use in animals will negatively impact meat production.”

Registrar of medicines Dr Joey Gouws said colistin use in humans and animals had been discussed at meetings in November and February and the matter was complex.

“The council [Medicines Control Council] required additional work and investigations to allow for further discussions [at a meeting] in June,” she said.

Department of Health spokesman Popo Maja said the department was very worried about antimicrobial resistance which, if not attended to, would become “an emerging catastrophe for human health”.

http://www.timeslive.co.za/sundaytimes/stnews/2016/03/20/Mutant-superbug-threat-to-SA-poultry

Posted in Uncategorized | Leave a comment

First instance of Colistin resistance bacteria in South Africa

Detected in China in November 2015, the Colistin resistant bacteria has been identified in South Africa by animal pharmaceutical company, V-Tech. The company has extensive national antimicrobial resistance (AMR) surveillance programmes, used by poultry producers, feedlots and piggeries in South Africa.

© decade3d – 123RF.com

© decade3d – 123RF.com

A new gene, which makes bacteria highly resistant to Colistin, what is commonly considered an antimicrobial of ‘last resort’, was found in poultry, pigs and people in China late last year and has already spread to other parts of Asia, as well as Europe and Africa, including the UK and Malaysia.
“What is worrying is that this gene, known as the MCR-1 gene, is already being transmitted between common bacteria such as E.coli, which can cause urinary tract and many other types of infection, and Klesbsiella pneumoniae, which causes pneumonia and other infections. This suggests the potential for it to spread between other bacterial populations, increasing the resistance to antimicrobials, or antibiotics,” says V-Tech CEO, Johan Oosthuyse.
This also comes at a time when concerns have been raised by the South African Poultry Association about poultry health standards in South Africa, as a result of the renewed terms of the African Growth and Opportunity Act (AGOA), strengthening the argument for surveillance programmes such as V-Tech’s, currently the only one of its kind in South Africa.
For the past eight years, V-Tech has conducted extensive surveillance of the use of antimicrobials in animals, and has promoted the responsible use of antimicrobials in animals. “Over 60% of poultry producers in the country use our surveillance programme, in which we manage the types of antimicrobials prescribed, the time needed to medicate the animals properly and the correct dosage to use.”

Surveillance programme

With this in mind, as soon as the threat of Colistin resistance was identified, V-Tech collaborated with bacteriologists in Switzerland and started developing a test to identify its presence using E.coli samples in its library. “As a result, we identified the presence of the MCR-1 gene in samples that have been collected from a number of South African poultry farms in the last quarter of 2015, as part of our programme.”
V-Tech has subsequently amended the surveillance programme to scan for the MCR-1 gene as routine going forward. This will enable the early identification of the E.coli that carries the gene and prevent the use of Colistin on farms where bacteria with the gene are present.
Oosthuyse says that Colistin may only be used in animals if prescribed by a veterinarian. “A strict protocol for veterinarians to prescribe Colistin for use in animals in future will be presented by V-Tech to the Department of Health by the end of January 2016. This will limit the risk of further spread of the MCR-1 gene and the resultant risk to humans, which is of concern given the increasing threat of AMR.”
He adds that V-Tech supports the prudent use of Colistin in animals. “Colistin remains an important antimicrobial in animal health and welfare and a total ban on its use in animals will negatively impact meat production, as there will be fewer treatment options available for sick animals. This will lead to even higher prices for meat and poultry, negatively impacting the consumer, who is already under severe pressure as a result of local economic conditions.”

 

 

Reference: http://www.bizcommunity.com/Article/196/151/139630.html

Posted in Uncategorized | Leave a comment

Worry as colistin resistance identified in SA

clip_image001

Bloemfontein – An animal pharmaceutical company intends briefing the Department of Health by the end of the month on a strict new veterinary protocol it believes necessary to regulate the use of the antibiotic colistin.

Farmer’s Weekly reports that V-Tech, which also conducts surveillance of antimicrobial resistance (AMR), has identified and confirmed the first ever known case in South Africa of resistance to colistin.

The report states that bacterial resistance to colistin is caused by the MCR-1 gene. V-Tech CEO Johan Oosthyse said in a statement it is especially worrying that this gene is already being transmitted between bacteria such as E. coli and Klebsiella pneumoniae.

The AMR surveillance programme is utilised by numerous poultry producers, piggeries and feedlots across South Africa. V-Tech says it intends amending the programme to include routine surveillance for the MCR-1 gene so that alternate antimicrobials can be used if the gene is present.

Oosthyse says they also intend going to Government with new protocols for veterinarians prescribing Colistin in future so as to limit risks of spreading the gene, as well as limiting risks to humans.

- See more at: http://www.ofm.co.za/article/news/177240/worry-as-colistin-resistance-identified-in-sa#sthash.CvTaLFjg.dpuf

Posted in Uncategorized | Leave a comment

Resistance to Colistin discovered in SA Poultry

farmers weekly titlefarmers weekly

http://www.farmersweekly.co.za/news.aspx?id=83305&h=Resistance-to-Colistin-discovered-in-SA-poultry

Posted in Uncategorized | Leave a comment

Landbou Weekblad Article

Graphic1Graphic2

Graphic3

Posted in Uncategorized | Leave a comment

The Rhino Orphanage

What is the Rhino Orphanage?

10906564_904597559573337_4193117088521625184_n“The Rhino Orphanage is a registered non-profit company based in the Limpopo Province and was founded by Arrie van Deventer in 2012. The orphanage is the first specialist, dedicated, non-commercial centre that cares for orphaned and injured baby rhinos with the only aim of releasing them back into the wild. It was created as the result of a lack of a specialized place for rearing baby rhinos who have been orphaned as a consequence of the current poaching crisis which feeds the illegal trade in horns.” http://therhinoorphanage.co.za/?gclid=CjwKEAjws7OwBRCn2Ome5tPP8gESJAAfopWsA-XDgXaFBu44iMnLQbKb7OKGrJo92u02yF8MAs_mbRoCqJzw_wcB

 

Facebook 2

V-Tech is a supporter of the Rhino Orphanage and recently donated some Biotizer to them. Biotizer is a blend of lysed Lactobacillus Acidophilus and Bifidium bacteria in a palatable carrier with a bacteria count of approximately 8 billion per ml. The bacteria are extensively used in both humans and animals and are produced by the Agricultural Research Council, Irene, South Africa. The bacteria found in Biotizer plays a major role in aiding digestion and reducing excessive gas and acids, and weight gain.

biotizers together

 

For more information on the Rhino Orphanage visit their website or Facebook page.

http://therhinoorphanage.co.za/

https://www.facebook.com/TheRhinoOrphanage/timeline

Posted in Uncategorized | 1 Comment

Prudent use of Antimicrobials in the Poultry Industry – The V-Tech Actif™ Plan

 

Poultry is one of the world’s fastest growing sources of meat, representing almost 35 % of all the meat produced during 2011 (WATT executive Guide 2011). Currently the industry can produce a broiler chicken ready for the market under six weeks. This is thanks to genetic selection, improved, feeding and health management practices, often involving the use of anti-microbials (AM) as therapeutic agents to treat bacterial disease in intensive farming practices. These antibiotics can be used either in feed or in water.

There has been an increase in bacterial resistance due to the need to use the anti-bacterial medicines.

Anti-microbial resistance (AMR) has become an international topic due to the increase in trends of resistance patterns. Most developed countries put plans and strategies in place to manage AMR. This global problem and its impact on the health of people and animals necessitated the development of the V-Tech Actif ™ plan.

Many anti-microbials are used in animals for metaphylactic treatment. Metapylaxis is the the application of anti-microbial medicines to groups of animals at times when an isolated few animals show symptoms of disease, and it is expected that a large portion of the group will become affected. This type of medication program to a flock of birds reduce overall mortality. It remains a challenge to manage bacterial diseases using narrow-spectrum anti-microbials. Veterinarians are often faced with the challenge to prescribe highly potent, modern antibiotics to effectively treat common conditions that were previously treated with over the counter antibiotics.

Classification of anti-microbial medicines.

1. Anti-microbial drugs developed for human therapy and which are not approved for use in food animals:

  • Lipopeptides, Oxazolidinones, Glycopeptides,Carbapenems, Third (or newer) generation tetracyclines (e.g., glycylcyclines) and Fifth (or newer) generation Cephalosporins (e.g., ceftaroline).

2. Critically important antimicrobials:

  • Aminoglycosides, cephalosporins (3rd and 4th generation), flouroquinolones, macrolides, penicillans, polymyxins.

3. Highly important anti-microbials:

  • Amphenicols, cephalosporins 91st and 2nd generations) lincosides, penicillans, sulphonaimides and combinations, tetracyclines.

4. Important anti-microbials

  • Aminocylitols, cyclic polypeptides, nitrofurantoins, nitroimidazoles

For the past 8 years V-Tech undertook to monitor and promote the responsible use of anti-microbials in the poultry industry. The V-Tech Actif™ Plan is comprised of three critical steps to assist in the management of anti-microbial use in Southern Africa:

· Specific

· Effective

· Safe

1. Specific

Once a bacterial disease is diagnosed by a veterinarian, V-Tech requires the submission of swabs from the areas of infection. In order to ascertain the bacterial cause of the infection a swap is submitted to a laboratory for culture. Once cultured the Minimum Inhibitory Concentration (MIC) for various anti-microbials is determined, figure 1.

image

Figure 1. Mean inhibitory concentration test (Dr TV Rao MD. ‘e’ learning resources for medical microbiologists in Developing world -https://muhammadcank.files.wordpress.com/2010/03/mic-peg.jpg)

These MIC results are of critical importance as they assist the consulting veterinarian and their client to determine the correct anti-microbial to use, to ensure that it is cost effective yet specifically targeted against the cultured bacteria. Figure 2 shows the results as seen in a MIC profile.

image

Figure 2: MIC profile for a poultry enterprise.

The results are analysed and identify the antibiotic that should best be used. To ensure the correct use of an antibiotic, the guiding principles for prudent use of anti-microbials are applied and verified on all farm operations raising food animals. A sound veterinary overview is important when anti-microbial use is required to maintain the health and welfare of animals. It is also important that the veterinarian takes note of the World Health Organization’s (WHO) characterization of critically, highly and important antimicrobials in human medicine. The choice of antibiotic should follow the decision path from least important for human medicines to important antibiotics.

· Anti-microbials that should not be used and will never be compounded by V-Tech1

· Critically important anti-microbials2

· Highly important anti-microbials3

· Important anti-microbials4

It is imperative once the drug of choice is selected, to ensure that the withdrawal period of the product is adhered to and only included for treatment in the stage of the production cycle, that will allow enough time for withdrawal before slaughter. This is to ensure that residues aren’t present in the final product that is marketed to the consumer and that the meat is safe for consumption.

2. Effective

Once the choice of medication was made an entire monitoring program is implemented. In the case of feed medication feed samples are analysed to confirm that the birds are treated at the prescribed level. This enables monitoring of correct inclusion levels, and to ensure that the medication is included in the correct ration, i.e starter, grower or finisher. The results are monitored very closely and any discrepancies are immediately discussed with the consulting veterinarian, the poultry producer and the feed mill. Same applies to water medication.

The dosage is of critical importance, since incorrect dosing can possibly perpetuate the problem of resistance in poultry, or a treatment that is ineffective for the diagnosed condition. Other problems could also arise in production parameters which could have a detrimental effect on the commercial enterprise. The next step in the monitoring program is the determination of serum levels of birds that are under medication to ensure that the medication reaches effective levels as determined in the MIC of the selected drug. This is crucial to ensure that the therapy is effective. Too low levels would not be effective and are promoting the faster development of resistant bacteria.

3. Safe

Finally, the last step in the Actif™ Plan is the screening of the final animal protein product for any antibiotic residue. This encompasses the involvement of the client, abattoirs and V-Tech. Residue monitoring is critical to ensure consumer safety and has now been established as standard operating practise.

At the abattoirs samples are taken from the liver and muscle for residue testing at a local accredited laboratory and must comply with MRL’s. Maximal Residue Levels (MRL) are published in the government gazette and are compliant with the Codex Alimentarius, an organisation set up by Food and Agriculture Organisation (FOA) and World Health Organisation (WHO). These MRL’s were determined from extensive research, to protect the consumer and ensure safe food standards.

AMR is today’s reality for both human and animal health and one that needs to be taken seriously. Since pathogens have no limit to their boundaries, South Africa is expected to play an important role in this fight against AMR. Veterinarians and other health officials together with companies like V-Tech need to hold hands and work together towards achieving the strategic objectives set out in the AMR strategy framework. It is globally a major concern that antibiotic resistance by organisms are increasing and may limit the availability of effective antibiotics in human medicine in the future.

V-Tech Activ ™ Plan is the answer to Continuous Anti-microbial Sensitivity Profile monitoring.

Dr Shannon Theobald BVSc, MSc (Agric)

Posted in Uncategorized | Leave a comment

2000 Snares in One Year

IMG_1325Ndzalama Wildlife Reserve, a 10 000 ha private wildlife reserve near Gravelotte in the Limpopo Province, recently released its anti – poaching statistics for 2014 and revealed that an alarming 2000 wire snares were removed by its anti-poaching unit off the reserve during this period. This reflects the national trend in wildlife poaching in South Africa as indicated by the increased number of recorded rhino that have been poached during the same period last year in South Africa.

Wildlife poaching seems to be on the increase in certain areas of South Africa and this also includes the poaching of wildlife owned by local communities. Ndzalama is a private wildlife reserve that belongs to the Balepye Community near Gravelotte in the Letaba valley and is managed as a partnership between the Balepye Community and private investors. The reserve creates employment for two different communities bordering on the reserve and is earmarked as a flagship project of the department of environmental affairs to allow ownership of wildlife, including rhino, by the communities. Although in its development phase, the reserve has already successfully introduced various management systems, including the anti – poaching project, which enables the participation of the communities in mainstream wildlife farming.

clip_image002One of the major challenges faced by the project has been the increasing poaching activities in the reserve. It was clear from the start that with the introduction of valuable wildlife onto the reserve, e.g. rhino, effective anti – poaching programs using community participation would need to be implemented. An anti – poaching unit under the management and training of a private security firm was established and members of the community were recruited to participate in formalized training in this regard. The result was that over 2000 snares were removed off the 10 000 ha reserve and one group of poachers was successfully arrested. The initiative was sponsored by V-Tech, a Midrand based Animal Health Company, as part of their social responsibility program.

“Unless rural communities experience the commercial benefit of wildlife ownership, we will never be able to effectively control poaching. The progress made with the anti-poaching activities on Ndzalama is encouraging and valuable lessons learned in the process. We will build on these experience gained in 2014 to further develop our anti – poaching program to control this continuous threat” Johan Meyer, Reserve Manager.

www.ndzalamalodge.co.za Ndzalama transparent logo

V_TECH LOGO_square

Posted in Uncategorized | Leave a comment